Department of Neuroscience, Carleton University, Ottawa, ON, Canada.
Department of Physiology, Institute of Biosciences of the University of São Paulo (IB/USP), São Paulo, São Paulo, Brazil.
Front Endocrinol (Lausanne). 2023 Jun 15;14:1189207. doi: 10.3389/fendo.2023.1189207. eCollection 2023.
Gestational diabetes (GDM) is associated with negative outcomes in mothers and their offspring, including greater risks of macrosomia at birth and the development of metabolic disorders. While these outcomes are well-established, the mechanisms by which this increased metabolic vulnerability is conferred on the offspring are comparatively lacking. One proposed mechanism is that maternal glycemic dysregulation alters the development of the hypothalamic regions related to metabolism and energy balance.
To investigate this possibility, in this study, we first examined the effects of STZ-induced maternal glucose intolerance on the offspring on pregnancy day (PD) 19, and, in a second experiment, in early adulthood (postnatal day (PND) 60). Whether effects would be influenced by sex, or exposure of offspring to a high-fat diet was also investigated. The impact of maternal STZ treatment on POMC neuron number in the ARC of offspring at both time points was also examined.
As expected, STZ administration on PD 7 decreased maternal glucose tolerance, and increased risk for macrosomia, and loss of pups at birth. Offspring of STZ-treated mothers were also more vulnerable to developing metabolic impairments in adulthood. These were accompanied by sex-specific effects of maternal STZ treatment in the offspring, including fewer POMC neurons in the ARC of female but not male infants in late pregnancy and a higher number of POMC neurons in the ARC of both male and female adult offspring of STZ-treated dams, which was exacerbated in females exposed to a high-fat diet after weaning.
This work suggests that maternal hyperglycemia induced by STZ treatment, in combination with early-life exposure to an obesogenic diet, leads to adult metabolic alterations that correlate with the increased hypothalamic expression of POMC, showing that maternal glycemic dysregulation can impact the development of hypothalamic circuits regulating energy state with a stronger impact on female offspring.
妊娠糖尿病(GDM)与母亲及其后代的不良结局相关,包括出生时巨大儿的风险增加以及代谢紊乱的发展。虽然这些结果已经得到证实,但导致后代代谢脆弱性增加的机制相对缺乏。一种提出的机制是,母体血糖失调改变了与代谢和能量平衡相关的下丘脑区域的发育。
为了研究这种可能性,在这项研究中,我们首先检查了 STZ 诱导的母体葡萄糖不耐受对后代妊娠第 19 天的影响,并在第二个实验中,在成年早期(产后第 60 天)进行检查。还研究了性别或后代暴露于高脂肪饮食是否会影响这些影响。还检查了母体 STZ 处理对两个时间点后代 ARC 中 POMC 神经元数量的影响。
正如预期的那样,PD7 时 STZ 给药会降低母体葡萄糖耐量,并增加巨大儿和出生时幼仔丢失的风险。STZ 处理母亲的后代在成年期也更容易出现代谢损伤。这些伴随着母体 STZ 处理在后代中的性别特异性影响,包括妊娠晚期雌性而非雄性婴儿 ARC 中的 POMC 神经元减少,以及 STZ 处理的母体断奶后暴露于高脂肪饮食的雌性和雄性后代 ARC 中 POMC 神经元数量增加,这种情况在雌性中更为严重。
这项工作表明,STZ 处理诱导的母体高血糖症,结合生命早期暴露于致肥胖饮食,导致与 POMC 表达增加相关的成年代谢改变,表明母体血糖失调会影响调节能量状态的下丘脑回路的发育,对雌性后代的影响更大。